CURE.X — Biocure Technology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Biocure Technology, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.159	0.038	0.004	0.018	0.041
Net Total Accounts Receivable
Net Total Receivables	1.9	0.022	0.007	0.008	0.003
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2.13	0.118	0.011	0.026	0.045
Net Property, Plant And Equipment	0.008	0	—	—	—
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	4.15	2.08	1.98	1.99	2.01
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.75	4.41	0.331	0.601	0.435
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	4.69	4.06	0.373	0.651	0.435
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.533	-1.98	1.6	1.34	1.58
Total Liabilities & Shareholders' Equity	4.15	2.08	1.98	1.99	2.01
Total Common Shares Outstanding